Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and trimethoprim, sulfamethoxazole drug combination

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with trimethoprim, sulfamethoxazole drug combination in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(trimethoprim, sulfamethoxazole drug combination)
Trials
(trimethoprim, sulfamethoxazole drug combination)
Recent Studies (post-2010) (trimethoprim, sulfamethoxazole drug combination)
9,1561875527,5278752,260

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dunoyer-Geindre, S; Girard, JP; Gumowski, PI; Ludi, F; Perez, T; Terki, N1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and trimethoprim, sulfamethoxazole drug combination

ArticleYear
PAF acether release on antigenic challenge. A method for the investigation of drug allergic reactions.
    Allergy, 1992, Volume: 47, Issue:1

    Topics: Antigens; Aspirin; Drug Hypersensitivity; Humans; Immunoglobulin E; Leukocytes; Lidocaine; Lymphocyte Activation; Penicillins; Platelet Activating Factor; Platelet Aggregation; Predictive Value of Tests; Quinolinium Compounds; Radioallergosorbent Test; Sensitivity and Specificity; Skin Tests; Trimethoprim, Sulfamethoxazole Drug Combination

1992